plasma peptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-10-17 and is reviewed periodically as new material appears.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence of three amino acids. The peptide was first isolated from human plasma in 1973 during research on factors that influence tissue repair in liver. Its ability to bind copper ions became a central point of interest because the metal changes the peptide's chemistry and its behaviour in laboratory systems. Today the compound appears in cosmetic formulations, cell-culture studies, and biochemistry literature under several names.
The peptide sequence places a histidine in the middle, and this residue dominates metal binding. Copper(II) coordinates through the imidazole nitrogen of histidine and the terminal amino group, forming a stable chelate ring system. Loss of the copper ion leaves the free tripeptide, which has different solubility and reactivity. This structural detail matters because assays that measure only the peptide backbone can miss whether copper is still bound to it.
The tripeptide was first isolated from a human plasma filtrate in 1973 during studies of tissue repair factors. Later work detected the free peptide and its copper complex in saliva, urine, and wound fluid, suggesting a natural role in tissue remodeling. Plasma concentrations reported in early literature decline with age, a pattern often cited in discussions of skin aging. Whether these endogenous levels are directly functional or largely incidental remains an open question. The peptide sequence is conserved across mammalian species.
Material described in research and cosmetic supply chains is typically a synthetic peptide supplied as a lyophilized powder. Purity is commonly reported through chromatographic separation, often at 95 percent or higher, while copper content is confirmed by separate elemental analysis. Batch variation in color and solubility can reflect residual counter-ions, moisture, or partial oxidation of the peptide. Because the complex is not a single regulatory entity, specifications differ between suppliers and are not standardized internationally.
| Property | Value | Notes |
|---|---|---|
| Peptide sequence | Gly-His-Lys | Three amino acids, histidine in the middle |
| Complex formula | C14H22CuN6O4 | One copper(II) ion per peptide |
| Molar mass (complex) | approx. 402.9 g/mol | Depends on counterion and hydration state |
| Appearance | Blue to blue-violet solid | Colour arises from copper coordination |
| Common synonyms | Copper tripeptide-1, GHK-Cu | Naming varies between disciplines |
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence found naturally in human plasma, saliva and urine. Loren Pickart reported the isolation of the free peptide in 1973 while studying factors that influenced the growth of aged liver cells in culture. The peptide was later shown to bind copper(II) with high affinity, and the metal-bound form became the focus of most subsequent research. Its concentration in circulation declines markedly with age, a pattern that is well documented, though the physiological consequences of that decline remain debated.
The peptide portion consists of three amino acids: glycine, histidine and lysine. Copper(II) coordinates through the imidazole nitrogen of histidine, the alpha-amino group of glycine and a deprotonated amide nitrogen of the backbone, producing a roughly square-planar geometry. This arrangement gives the complex its characteristic blue-to-violet colour and helps it resist dissociation in water. Reported stability constants are high, although values differ between studies because of differences in ionic strength and measurement method.
The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.
The sequence carries three residues in the order glycine, histidine, lysine, which places a small, flexible chain around a single metal centre. Compared with larger copper-binding proteins, the complex is compact and its coordination chemistry can be reproduced with synthetic peptide in a laboratory. Published structural work agrees on the nitrogen donor set but differs in the exact geometry assigned under some conditions, so the arrangement is best treated as well characterised in outline rather than fixed in every detail.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide was isolated from human plasma in the early 1970s by Loren Pickart, who observed that a plasma fraction from young donors stimulated growth in cultured liver cells. The copper-bound form is abbreviated GHK-Cu, while the metal-free peptide is written simply as GHK. In the research literature the complex also appears as copper tripeptide-1 and as glycyl-histidyl-lysine copper complex.
Copper(II) binds the peptide through four nitrogen donors: the terminal amino group, the imidazole nitrogen of histidine, and two deprotonated amide nitrogens of the peptide backbone. This tetradentate arrangement gives a roughly square-planar geometry, the thermodynamically favoured form near neutral pH. Because the amide nitrogens must lose a proton before they can coordinate, complex formation is strongly pH-dependent, and the fully coordinated species dominates only above mildly acidic conditions. Electronic transitions within the copper d orbital set produce the characteristic blue to violet colour in aqueous solution.
Veterinarians also administer transfusions to other animals. Various species require different levels of testing to ensure a compatible match. For example, cats have 3 known blood types, cattle have 11, dogs have at least 13, pigs have 16, and horses over 30. However, in many species (especially horses and dogs), cross matching is not required before the first transfusion, as antibodies against non-self cell surface antigens are not expressed constitutively – i.e. the animal has to be sensitized before it will mount an immune response against the transfused blood. The rare and experimental practice of inter-species blood transfusions (xenotransfusion) is a form of xenograft.
== History == A phase III trial published in 2019 showed people treated with elexacaftor/tezacaftor/ivacaftor improved in FEV1 at four weeks with sustained improvement at 24 weeks. Rate of pulmonary exacerbation was 63% lower and sweat chloride concentration was 41.8 mmol/L lower.
== External links == Legio X – Legio X Gemina (Equites) – "Viri Clarissimi" Livius.org: List of Roman legions Archived 2014-06-26 at the Wayback Machine A catalogue of Roman legions Legio V Living History Group in Tennessee Roman legions from Dacia (KML file) Archived 2012-01-20 at the Wayback Machine
=== Antibiotic resistance === S. haemolyticus has the highest level of antibiotic resistance among the CoNS. Various strains are resistant to one or more of these antibiotics: penicillins, cephalosporins, macrolides, quinolones, tetracyclines, aminoglycosides, glycopeptides, and fosfomycin (see table in Genome structure), and multidrug resistance is common. As indicated above, even glycopeptide-resistant (vancomycin and teicoplanin) strains have begun to emerge.
Sources: en.wikipedia.org
=== Committee assignments === As an independent, Sanders maintains an agreement with the Senate Democratic leadership where he votes with the Democrats on all procedural matters unless the Democratic whip, Dick Durbin, agrees that he need not (a request rarely made or granted). In return he was allowed to keep his seniority and received the committee seats that would have been available to him as a Democrat; in 2013–14 he was chairman of the United States Senate Committee on Veterans' Affairs (during the Veterans Health Administration scandal). Sanders became the ranking minority member on the Senate Budget Committee in 2015 and the chair in 2021; he previously chaired the Senate Veterans' Affairs Committee for two years. Since 2017, he has been chair of the Senate Democratic Outreach Committee. He appointed economics professor Stephanie Kelton, a modern monetary theory scholar, as the chief economic adviser for the committee's Democratic minority and presented a report about helping "rebuild the disappearing middle class" that included proposals to raise the minimum wage, boost infrastructure spending, and increase Social Security payments.
=== Rosetta stone (gene fusion) method === The Rosetta Stone or Domain Fusion method is based on the hypothesis that interacting proteins are sometimes fused into a single protein. For instance, two or more separate proteins in a genome may be identified as fused into one single protein in another genome. The separate proteins are likely to interact and thus are likely functionally related. An example of this is the Human Succinyl coA Transferase enzyme, which is found as one protein in humans but as two separate proteins, Acetate coA Transferase alpha and Acetate coA Transferase beta, in Escherichia coli. In order to identify these sequences, a sequence similarity algorithm such as the one used by BLAST is necessary. For example, if we had the amino acid sequences of proteins A and B and the amino acid sequences of all proteins in a certain genome, we could check each protein in that genome for non-overlapping regions of sequence similarity to both proteins A and B. Figure B depicts the BLAST sequence alignment of Succinyl coA Transferase with its two separate homologs in E. coli. The two subunits have non-overlapping regions of sequence similarity with the human protein, indicated by the pink regions, with the alpha subunit similar to the first half of the protein and the beta similar to the second half. One limit of this method is that not all proteins that interact can be found fused in another genome, and therefore cannot be identified by this method. On the other hand, the fusion of two proteins does not necessitate that they physically interact.
== Description == The fool's mushroom is pure white, all the way to the gills and the stipe. This fungus, like many but not all amanitas, has a volva. The fool's mushroom's cap is 5–10 centimetres (2–4 inches) wide, and is about the same height. This mushroom's lamellae are free and white, and the volva is bag-like and large. Its annulus is white and membranous, and A. verna react yellow with 20% potassium hydroxide solution, unlike its relative Amanita phalloides var. alba while Amanita virosa gets an orange-yellow reaction. The mushroom's spores are smooth and elliptical.
Sources: en.wikipedia.org
=== 1970s: Heseltine takes ownership of Haymarket === In 1970, Heseltine turned down the chance to invest £25,000 in the advertising agency Saatchi & Saatchi when it was set up (his former employee Maurice Saatchi said that he had learned a great deal from Heseltine's aggressive techniques of acquiring magazine titles, and from publicity in Campaign magazine), believing wrongly that it was against the code for ministers to make such an investment. Lindsay Masters did invest, but was eventually bought out by the Saatchi brothers; Heseltine later believed that he and Masters together could have made another fortune if they had reinforced one another with large shareholdings in Saatchi and Saatchi. With Heseltine a government minister from June 1970, Haymarket was being run by Masters and Tindall, who had secured another coup by publishing Computing for the British Computing Society. BPC was in financial trouble in 1971, and Heseltine, Masters and Tindall assembled a consortium of County Bank, Charterhouse Development, ICFC and Wren Investments to help buy out BPC's 60% stake for £1m, a very low price given that Haymarket had made over £250,000 the previous year. The consortium took a 40% stake in Haymarket, and loaned the company £820,000, while Heseltine took out a large personal loan at this time to buy both another 20% of Haymarket's shares (the rest of the BPC shareholding, bringing Heseltine's own shareholding to just under 50%).
Human and mouse protein kinases in UniProt: classification and index Kinase.Com: Genomics, evolution and large-scale analysis of protein kinases (non-commercial). KinMutBase: A registry of disease-causing mutations in protein kinase domains Archived 2022-06-15 at the Wayback Machine KLIFS (Kinase-Ligand Interaction Fingerprints and Structures) Database -- analysis of kinase structures and kinase-inhibitor interactions KinCore: the Kinase Conformation Resource: A web resource for protein kinase sequence, structure and phylogeny Kinomer: A multilevel HMM library for the classification and functional annotation of eukaryotic protein kinases.
Maurice "Moe" Granat (84) (2007) Gladys Millard (87) (2011) Helen Matheson (95) (2011) Mary Zurawinski (96) (2011) Helen Young (90) (2013) Maureen Pickering (79) (2014) While at Caressant Care, Wettlaufer also injected Michael Priddle (63) and Wayne Hedges (57) "with intent to murder". She confessed to two counts of attempted murder in these cases. She left employment at Caressant Care in 2014, but in part-time work at other facilities and at patients' homes, she injected three more people with insulin:
When there is an injury to a blood vessel, the endothelial cells can release various vasoconstrictor substances, such as endothelin and thromboxane, to induce the constriction of the smooth muscles in the vessel wall. This helps reduce blood flow to the site of injury and limits bleeding.
Sources: en.wikipedia.org
The peptide is glycyl-L-histidyl-L-lysine, a three-amino-acid sequence commonly abbreviated GHK. It binds a single copper(II) ion under typical laboratory conditions. The free peptide and the copper complex are separate chemical species with different properties.
The sequence was identified in human plasma in 1973. Early work examined its presence in blood and its proposed role in tissue repair. The copper-binding property was characterized afterward and became the focus of much later research.
The tripeptide has been measured in human plasma and other biological fluids. Whether it circulates mainly as the copper complex or as the free peptide remains an open question. Natural concentrations are low and difficult to measure reliably.
It is a complex of the tripeptide glycyl-L-histidyl-L-lysine with a copper(II) ion. The peptide coordinates the metal through its histidine, amino terminus, and an amide nitrogen. It is often listed simply as copper tripeptide-1.